Hims & Hers unlawfully mass markets unapproved versions of Novo Nordisk’s FDA-approved semaglutide medicines, deceiving ...

Novo Nordisk A/S NVO on Monday said it has filed a lawsuit against telehealth company Hims & Hers Inc. HIMS for infringing U.S. Patent 8,129,343 with Hims’ compounded semaglutide products for the U.S.

OpenClaw turns LLMs into autonomous agents that actually do stuff. Here is a hands-on reality check of running it on local hardware and burner phones.

Advertising is entering a new phase as OpenAI begins testing ads within ChatGPT, marking a significant shift for one of the ...

Halo Pharma's transition to a standalone CDMO allows a concentrated focus on drug product services, enhancing technical ...

Anthropic has officially launched Claude Opus 4.6, featuring a massive 1M token context window, advanced agentic coding, and more.

Freshsales CRM stands out for its user-friendly interface, comprehensive core capabilities, and flexible pricing model. The ...

Deciso(R) is proud to announce OPNsense(R) 26.1, code-named 'Witty Woodpecker.' This latest Community Edition release strengthens OPNsense's security foundation while improving network visibility, ...

OpenAI isn't resting on its laurels when it comes to its ever-popular ChatGPT chatbot. Here are four notable changes coming ...

Despite lots of hype, "voice AI" has so far largely been a euphemism for a request-response loop. You speak, a cloud server ...

Discover Claude Opus 4.6 from Anthropic. We analyze the new agentic capabilities, the 1M token context window, and how it outperforms GPT-5.2 while addressing critical trade-offs in cost and latency.